Daniela Josefa Díaz Catalán
Postdoctotal Researcher
Universidad Mayor de Chile
Santiago, Chile
My research integrates molecular and computational approaches to study metabolic diseases, endocrine dysfunctions, and translational biomedical applications, aiming to advance precision medicine and patient outcomes.
-
Biomedicine, UNIVERSIDAD DE BARCELONA. España, 2021
-
Bioinformatic and Biostatistic, UNIVERSIDAD OBERTA DE CATALUNYA. Chile, 2024
-
Biomedical Research, UNIVERSITAT POMPEU FABRA. España, 2016
-
Médico Veterinario, UNIVERSIDAD MAYOR. Chile, 2014
-
Junior Biostatistician Full Time
European Foundation Chonic Liver Failure (EF CLIF)
Barcelona, España
2024 - 2025
-
Junior Bioinformatician Scientist Full Time
Hospital del Mar Research Institute (IMIM)
Barcelona, España
2024 - 2024
-
Postdoc Scientist Full Time
August Pi Sunyer Biomedical Research Institute (IDIBAPS)
Barcelona, España
2021 - 2023
-
Predoctoral Scientist Full Time
August Pi Sunyer Biomedical Research Institute (IDIBAPS)
Barcelona, España
2017 - 2021
-
Master Scientist Full Time
Barcelona University
Barcelona, España
2016 - 2016
-
Research Assistant Part Time
Universitat Oberta de Catalunya
Barcelona, España
2025 - A la fecha
-
Postdoc Scientist Full Time
Universidad Mayor
Santiago, Chile
2025 - A la fecha
Publications:
- Authored 10 peer-reviewed articles in high-impact journals such as Molecular Metabolism and Scientific Reports. These publications address critical topics like the metabolic consequences of BACE2 suppression in obesity and the therapeutic potential of FGF21 in Cushing syndrome.
- Contributions to interdisciplinary research have bridged molecular biology, clinical applications, and computational analysis.
Conference Presentations:
- Presented at 9 international conferences, including prestigious events like the European Congress of Endocrinology (ECE) and the Sociedad Española de Endocrinología y Nutrición (SEEN).
- Delivered oral presentations and posters on topics ranging from fibroblast growth factor 21's role in adrenal renewal to BACE2 deficiency's impact on metabolic health.
- Recognized with the Best Oral Presentation Award at the III Biomed PhD Day (2019), highlighting your ability to communicate complex scientific findings effectively.
Knowledge Transfer Initiatives:
- Coordinated the Red de Investigadores/as Chilenos/as en España (RedINCHE), creating spaces for reflection and dissemination in biomedicine.
- Co-coordinated the session on biomedicine at the "Red Encuentros Barcelona 2016," fostering collaboration among researchers.
Collaborations:
- Worked with international teams, such as Dr. Vallejo's group at IIBM Alberto Sols (Madrid) and Dr. Claret's team at IDIBAPS, to advance calorimetry and appetite regulation research.
- Supervised master's theses and undergraduate projects, contributing to capacity building in biomedical research.
-
PREDOCTORAL FELLOWSHIP CONICYT
UNIVERSIDAD DE BARCELONA
Chile, 2016
Programa de fromación de Capital humano Avanzado de la Comisión Nacional de Investigación Científica y Tecnológica (CONICYT)
-
FELLOWSHIP
European Society Endocronology Young Endocrinologists and Scientists (EYES)
Croacia, 2022
FELLOWSHIP from European Society Endocronology Young Endocrinologists and Scientists (EYES) to 9th European Society Endocronology Young Endocrinologists and Scientists (EYES) meeting.
-
FELLOWSHIP
European Association for the Study of Diabetes (EASD)
Francia, 2018
FELLOWSHIP from European Association for the Study of Diabetes (EASD) to assit Scientists Training Course.
-
BEST ORAL PRESENTATION
Universitat de Barcelona
España, 2019
BEST ORAL PRESENTATION “Bace2 as a new therapeutic target for the treatment of obesity and type 2 Diabetes” III Biomed PhD day.
8092 Senecence Cell Accumulation In Cushing Syndrome |
Effects of Fibroblast factor 21 to adrenal renewal after chronic hypercortisolism |
Daniela Díaz
Postdoctotal Researcher
Facultad de Medicina y Ciencias de la Salud
Universidad Mayor de Chile
Santiago, Chile